Dual therapy with immune checkpoint inhibitors does not appear to prolong overall survival as compared with sunitinib alone for advanced renal cell carcinoma patients with favourable risk, according to the results of a meta-analysis.
The risk of developing advanced colorectal neoplasia in patients with chronic kidney disease (CKD) is strongly associated with older age, male sex, and exposure to erythropoiesis-stimulating agents and azathioprine, a study has found.
Systemic melanoma treatment does not lead to increased toxicity in older adults and may yield slight survival benefits, a recent study has found. Nevertheless, death from causes other than melanoma contributes to a lower overall survival (OS) in older patients.
Use of atorvastatin for a year appears to confer no benefit for the risk of disease recurrence among prostate cancer patients with high-risk pathologic features who have undergone radical prostatectomy, a study has found.
Individuals with a family history of Barrett's oesophagus or oesophageal adenocarcinoma (OAC) are at risk of developing the said diseases, according to the results of a systematic review and meta-analysis.
There seems to be an increasing trend in the diagnosis rate of benign prostatic hyperplasia (BPH), accompanied by a gradual rise in medical treatment and decline in surgical interventions, a new South Korea study has shown.
Treatment with perioperative cisplatin-capecitabine (CX) with preoperative chemoradiation (CRT) is feasible in patients with advanced gastric cancer (GC) in real-world settings of a public-sector hospital from a low-middle-income country, a study has shown.